Neil Canavan
Neil Canavan has been a journalist for over 20 years. He spent most of his career writing about science and medicine. His articles have appeared on WebMD, Medscape, The Scientist, and Drug Discovery and Development magazine. For the last 5 years, he reported on issues related to drug development in cancer. Furthermore, since 2014 Neil has held the position of scientific advisor at The Trout Group, a New York based investor relations firm focused on healthcare biotechnology. Currently, he is a contributing editor to the Oncology Business Review. Neil recently added “author” to his long list of accomplishments with the release of his book “A Cure Within: Scientists Unleashing the Immune System to Kill Cancer.”
